Murray, Heather C.
Enjeti, Anoop K.
Kahl, Richard G. S.
Flanagan, Hayley M.
Sillar, Jonathan
Skerrett-Byrne, David A. http://orcid.org/0000-0002-1804-1826
Al Mazi, Juhura G.
Au, Gough G.
de Bock, Charles E. http://orcid.org/0000-0001-5182-8535
Evans, Kathryn
Smith, Nathan D.
Anderson, Amanda
Nixon, Brett
Lock, Richard B.
Larsen, Martin R.
Verrills, Nicole M. http://orcid.org/0000-0002-7894-0137
Dun, Matthew D. http://orcid.org/0000-0002-9063-5370
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1157871)
Cancer Institute NSW (MD00487, 13/ECF/1-34)
Article History
Received: 18 May 2020
Revised: 23 August 2020
Accepted: 29 September 2020
First Online: 16 October 2020
Compliance with ethical standards
:
: The DNA-PK inhibitor, M3814, used in this study was supplied by EMD-Serono Research & Development Institute, Massachusetts, USA under a materials transfer agreement with NMV and the University of Newcastle, Callaghan, Australia.